Dissecting out the genetic origins of Barrett's oesophagus

Gut

Volumn 57, Issue 8, 2008, Pages 1033-1034

  Fitzgerald, Rebecca C ^a  

^a HUTCHISON MRC RESEARCH CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PROTEIN P16; PROTEIN P53;

BARRETT ESOPHAGUS; DYSPLASIA; ESOPHAGUS BIOPSY; FLUORESCENCE ACTIVATED CELL SORTING; GENE AMPLIFICATION; GENETIC HETEROGENEITY; GENETIC SCREENING; GENETIC SELECTION; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; METAPLASIA; MICRODISSECTION; MOLECULAR BIOLOGY; MOLECULAR EVOLUTION; NOTE; PRIORITY JOURNAL;

BARRETT ESOPHAGUS; ESOPHAGEAL NEOPLASMS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; PRECANCEROUS CONDITIONS;

EID: 48249134659     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2008.151530     Document Type: Note

References (16)

1. Nowell PC. The clonal evolution of tumor cell populations. Science 1976;194:23-8.
2. Maley CC, Galipeau PC, Li X, et al. Selectively advantageous mutations and hitchhikers in neoplasms: p16 lesions are selected in Barrett's esophagus. Cancer Res 2004;64:3414-27.
3. Leedham SJ, Preston SL, McDonald SA, et al. Individual crypt genetic heterogeneity and the origin of metaplastic glandular epithelium in human Barrett's oesophagus. Gut 2008;57;1041-8.
4. Maley CC, Galipeau PC, Li X, et al. The combination of genetic instability and clonal expansion predicts progression to esophageal adenocarcinoma. Cancer Res 2004;64:7629-33.
5. Bhowmick NA, Chytil A, Plieth D, et al. TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science 2004;303:848-51.
6. Mueller MM, Fusenig NE. Friends or foes - bipolar effects of the tumour stroma in cancer. Nat Rev Cancer 2004;4:839-49.
7. Fukino K, Shen L, Patocs A, et al. Genomic instability within tumor stroma and clinicopathological characteristics of sporadic primary invasive breast carcinoma. Jama 2007;297:2103-11.
8. Maley CC, Galipeau PC, Finley JC, et al. Genetic clonal diversity predicts progression to esophageal adenocarcinoma. Nat Genet 2006;38:468-73.
9. Biddlestone L, Barham C, Wilkinson S, et al. The histopathology of treated Barrett's esophagus: squamous reepithelialization after acid-suppression and laser photodynamic therapy. Am J Surg Pathol 1998;22:239-45.
10. Chang CL, Lao-Sirieix P, Save V, et al. Retinoic acid-induced glandular differentiation of the oesophagus. Gut 2007;56:906-17.
11. Coad RA, Woodman AC, Warner PJ, et al. On the histogenesis of Barrett's oesophagus and its associated squamous islands: a three-dimensional study of their morphological relationship with native oesophageal gland ducts. J Pathol 2005;206:388-94.
12. Paulson TG, Xu L, Sanchez C, et al. Neosquamous epithelium does not typically arise from Barrett's epithelium. Clin Cancer Res 2006;12:1701-6.
13. Maley CC. Open questions in oesophageal adenocarcinogenesis. Gut 2007;56:897-8.
14. McDonald SA, Greaves LC, Gutierrez-Gonzalez L, et al. Mechanisms of field cancerization in the human stomach: the expansion and spread of mutated gastric stem cells. Gastroenterology 2008;134:500-10.
15. McDonald SA, Preston SL, Greaves LC, et al. Clonal expansion in the human gut: mitochondrial DNA mutations show us the way. Cell Cycle 2006;5:808-11.
16. Braun KM, Niemann C, Jensen UB, et al. Manipulation of stem cell proliferation and lineage commitment: visualisation of label-retaining cells in wholemounts of mouse epidermis. Development 2003;130: 5241-55.